Analyst Ranking
Bottom 15%
#4260 out of 4986 analysts
Average Return
-0.51%
Win Rate
42%16 out of 38
Risk vs Reward
Poor
Good

Matt Hewitt's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Avid Bioservices IncCDMO
+164.66%$4.64$12.28
2023-12-08 -
2024-12-06
Buy
Simulations Plus IncSLP
+142.31%$31.01$75.14
2020-01-06 -
2021-01-06
Buy
Biolife Solutions IncBLFS
+103.30%$12.42$25.25
2023-08-10 -
2024-08-09
Buy
Inotiv IncNOTV
+95.69%$2.55$4.99
2023-12-12 -
2024-12-11
Buy
Champions Oncology IncCSBR
+70.85%$4.46$7.62
2024-09-12 -
2025-08-19
Buy

Matt Hewitt Analyst Color

Get additional color on Matt Hewitt's coverage of popular stocks

Matt Hewitt's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Simulations Plus IncSLP
8Buy$36.00+156.05%Maintains
2 months ago
Champions Oncology IncCSBR
3Buy$12.00+57.48%Maintains
5 months ago
Clover Health Investments CorpCLOV
1Buy$6.00+138.10%Initiates Coverage On
8 months ago
Biolife Solutions IncBLFS
4Buy$32.00+30.40%Maintains
9 months ago
Omnicell IncOMCL
2Buy$64.00+100.56%Maintains
10 months ago
Ligand Pharmaceuticals IncLGND
2Buy$140.00N/AMaintains
a year ago
Inotiv IncNOTV
3Buy$10.00N/AMaintains
a year ago
Schrodinger IncSDGR
3Buy$30.00N/AMaintains
a year ago
Agiliti IncAGTI
1Buy$23.00N/AInitiates Coverage On
2 years ago
Avid Bioservices IncCDMO
3Buy$16.00N/AMaintains
2 years ago
Maxcyte IncMXCT
1Buy$7.00N/AInitiates Coverage On
2 years ago
Repligen CorpRGEN
2Buy$200.00N/AMaintains
2 years ago
Omniab IncOABI
1Buy$10.00N/AInitiates Coverage On
2 years ago
Surgalign Holdings IncSRGAQ
2Hold$2.00N/AMaintains
2 years ago
Science 37 Holdings IncSNCE
1Buy$200.00N/AInitiates Coverage On
3 years ago
Cynergistek IncCTEK
1Hold$1.25N/ADowngrades
3 years ago
Teladoc Health IncTDOC
4Hold$30.00N/AMaintains
3 years ago
Ispecimen IncISPC
1Buy$400.00N/AInitiates Coverage On
4 years ago
Vocera Communications IncVCRA
1Buy$30.00N/AUpgrades
5 years ago
Apollo Endosurgery IncAPEN
1Buy$11.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.